Objective: The burden of cancer prevalence and mortality poses challenges to global cancer care delivery, particularly impacting low- and middle-income countries in accessing evidence-based cancer prevention, treatment, and supportive care. Integrative oncology integrates traditional, complementary, and integrative medicine with standard cancer therapies to enhance healthcare delivery. This study aims to evaluate the anti-cancer properties of kombucha tea across multiple cancer types. Materials and Methods: Various databases, including PubMed, Science Direct, and Scopus, reviewed for recent research on kombucha tea's potential benefits and impact on cancer. Results: Recent research developments highlight kombucha tea as a potential aid in enhancing cancer resistance and offering various health benefits. Conclusion: Integrative oncology, complemented by the consumption of kombucha tea, presents a promising approach to addressing the complexities of cancer care. Further exploration and updates on kombucha tea anti-cancer properties against breast, lung, liver, colorectal, ovarian, uterine, and prostate cancers are warranted to enhance comprehensive understanding and potential therapeutic applications.
Sarshar et al. (Tue,) studied this question.